MedTrace Logo

Outcome of Chronic Subdural Hematoma Management With Double Burr Hole Craniotomy Versus Single Burr Hole Craniotomy and Subdural Drain Evacuation

NCT07368101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-26

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the outcome of double burr hole versus single burr hole in patients of chronic subdural hematoma undergoing subdural drain evacuation.

The main questions it aims to answers are

1\. Which one of the surgical method i.e single burr hole or double burr hole is clinically superior with better post operative prognosis for the drainage of chronic subdural hematoma.

2 Compare the post operative complications in both the techniques in term of wound infection hospital stay duration , recurrence and mortality.

participants will be divided in two groups one group will be treated with single burr hole technique second group will be treated with double burr hole technique.

After procedure, patients will be followed-up in hospital until discharge and total hospital stay will be noted. Patients will be followed-up further in OPD . During follow-up, patients will be evaluated for wound infection, recurrence and mortality.

Conditions

  • Chronic Subdural Hematoma

Interventions

PROCEDURE

Single Burr hole Craniotomy

Single Burr hole made at the point of highest collection of hematoma in subdural space in brain.

PROCEDURE

Double Burr hole Craniotomy

Two burr hole made in skull each at parietal eminence and around superior temporal line to drain chronic subdural hematoma

Sponsors & Collaborators

  • Services Institute of Medical Sciences, Pakistan

    lead OTHER_GOV

Principal Investigators

  • Muhammad Hassan Tabish, MBBS · Services Hospital / Services Institute of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-04
Primary Completion
2025-03-07
Completion
2025-05-09

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07368101 on ClinicalTrials.gov